{"id":26143,"date":"2024-10-08T09:52:05","date_gmt":"2024-10-08T07:52:05","guid":{"rendered":"https:\/\/www.chemsafe-consulting.com\/?p=26143"},"modified":"2024-10-08T10:34:53","modified_gmt":"2024-10-08T08:34:53","slug":"how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry","status":"publish","type":"post","link":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/","title":{"rendered":"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry"},"content":{"rendered":"<div class=\"vc_acf vc_txt_align_left field_5a155fb5628a4\">\n<p>The pharmaceutical industry stands at the crossroads of significant transformation as Europe rethinks its global competitiveness strategy. Former Italian Prime Minister Mario Draghi recently presented a comprehensive report outlining bold reforms aimed at strengthening Europe\u2019s economy. While this vision addresses a broad range of sectors, the implications for the pharmaceutical industry are particularly notable. But what does this future look like, and how could these changes affect pharma companies? Let\u2019s dive into how Draghi\u2019s vision could reshape the pharmaceutical landscape in Europe.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Boosting Investment in Pharma Innovation<\/strong><\/h4>\n<p>One of the key takeaways from Draghi\u2019s report is the call for Europe to significantly ramp up its investments in research and development (R&amp;D). For the pharmaceutical industry, which thrives on innovation, this could be a game-changer. The proposal suggests that Europe should raise its investment levels by up to \u20ac800 billion a year across various sectors. Given that R&amp;D forms the backbone of the pharma industry, this injection of funds could accelerate the development of new drugs and medical technologies, positioning European companies to compete more effectively with global players.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Streamlining Regulatory Processes for Faster Approvals<\/strong><\/h4>\n<p>Pharmaceutical companies often face long and complex approval processes when bringing new treatments to market. Draghi\u2019s report recognizes this challenge and calls for simplifying regulatory frameworks across Europe. A more streamlined and harmonized approach could allow for faster approval times, giving companies the agility they need to innovate and respond quickly to health crises. This would not only benefit companies but also patients, as new treatments could reach the market more swiftly.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Strengthening Pharma Supply Chains<\/strong><\/h4>\n<p>Supply chain resilience is another focal point in Draghi\u2019s report. Europe\u2019s pharmaceutical industry has faced disruptions, particularly during the COVID-19 pandemic, due to reliance on imports of critical raw materials. By reinforcing supply chains and boosting the domestic production of APIs, Europe could secure a more stable and reliable pharma supply chain. This would reduce the sector\u2019s dependence on external sources and help avoid potential bottlenecks in the future.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>A balanced Approach to Pharma\u2019s Future in Europe<\/strong><\/h4>\n<p>Mario Draghi&#8217;s vision for boosting Europe\u2019s competitiveness offers the pharmaceutical industry a path to stronger innovation, more efficient regulatory processes, and improved operational costs. However, the success of these initiatives will depend on the implementation of long-term reforms and the ability to harmonize policies across diverse EU member states. Draghi&#8217;s recommendations provide a hopeful roadmap, but realizing their full potential will require collaboration between governments, industries, and other stakeholders.<\/p>\n<p>&nbsp;<\/p>\n<p>What do you think about Draghi\u2019s plan?<\/p>\n<p>&nbsp;<\/p>\n<p>Sources:<a href=\"https:\/\/commission.europa.eu\/topics\/strengthening-european-competitiveness\/eu-competitiveness-looking-ahead_en#paragraph_47059\"> https:\/\/commission.europa.eu\/topics\/strengthening-european-competitiveness\/eu-competitiveness-looking-ahead_en#paragraph_47059<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The pharmaceutical industry stands at the crossroads of significant transformation as Europe rethinks its global competitiveness strategy. Former Italian Prime Minister Mario Draghi recently presented a comprehensive report outlining bold reforms aimed at strengthening Europe\u2019s economy. While this vision addresses a broad range of sectors, the implications for the pharmaceutical industry are particularly notable. But what does this future look like, and how could these changes affect pharma companies? Let\u2019s dive into how Draghi\u2019s vision could reshape the pharmaceutical landscape in Europe. &nbsp; Boosting Investment in Pharma Innovation One of the key takeaways from Draghi\u2019s report is the call for Europe to significantly ramp up its investments in research and development (R&amp;D). For the pharmaceutical industry, which thrives on innovation, this could be a game-changer. The proposal suggests that Europe should raise its investment levels by up to \u20ac800 billion a year across various sectors. Given that R&amp;D forms the backbone of the pharma industry, this injection of funds could accelerate the development of new drugs and medical technologies, positioning European companies to compete more effectively with global players. &nbsp; Streamlining Regulatory Processes for Faster Approvals Pharmaceutical companies often face long and complex approval processes when bringing new treatments to&#8230;<\/p>\n","protected":false},"author":2,"featured_media":26144,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53,66],"tags":[],"class_list":["post-26143","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-pharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry - ChemSafe<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry\" \/>\n<meta property=\"og:description\" content=\"The pharmaceutical industry stands at the crossroads of significant transformation as Europe rethinks its global competitiveness strategy. Former Italian Prime Minister Mario Draghi recently presented a comprehensive report outlining bold reforms aimed at strengthening Europe\u2019s economy. While this vision addresses a broad range of sectors, the implications for the pharmaceutical industry are particularly notable. But what does this future look like, and how could these changes affect pharma companies? Let\u2019s dive into how Draghi\u2019s vision could reshape the pharmaceutical landscape in Europe. &nbsp; Boosting Investment in Pharma Innovation One of the key takeaways from Draghi\u2019s report is the call for Europe to significantly ramp up its investments in research and development (R&amp;D). For the pharmaceutical industry, which thrives on innovation, this could be a game-changer. The proposal suggests that Europe should raise its investment levels by up to \u20ac800 billion a year across various sectors. Given that R&amp;D forms the backbone of the pharma industry, this injection of funds could accelerate the development of new drugs and medical technologies, positioning European companies to compete more effectively with global players. &nbsp; Streamlining Regulatory Processes for Faster Approvals Pharmaceutical companies often face long and complex approval processes when bringing new treatments to...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"ChemSafe\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-08T07:52:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-08T08:34:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gabriele Pincitore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriele Pincitore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\"},\"author\":{\"name\":\"Gabriele Pincitore\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119\"},\"headline\":\"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry\",\"datePublished\":\"2024-10-08T07:52:05+00:00\",\"dateModified\":\"2024-10-08T08:34:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\"},\"wordCount\":458,\"publisher\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg\",\"articleSection\":[\"Blog\",\"Pharma\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\",\"name\":\"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry - ChemSafe\",\"isPartOf\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg\",\"datePublished\":\"2024-10-08T07:52:05+00:00\",\"dateModified\":\"2024-10-08T08:34:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg\",\"contentUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg\",\"width\":1280,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.chemsafe-consulting.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#website\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/\",\"name\":\"ChemSafe\",\"description\":\"Your lighthouse in a sea of rules\",\"publisher\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.chemsafe-consulting.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#organization\",\"name\":\"ChemSafe\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png\",\"contentUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png\",\"width\":170,\"height\":69,\"caption\":\"ChemSafe\"},\"image\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/chemsafe-srl\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119\",\"name\":\"Gabriele Pincitore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g\",\"caption\":\"Gabriele Pincitore\"},\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/author\/chemsafe\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry - ChemSafe","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/","og_locale":"it_IT","og_type":"article","og_title":"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry","og_description":"The pharmaceutical industry stands at the crossroads of significant transformation as Europe rethinks its global competitiveness strategy. Former Italian Prime Minister Mario Draghi recently presented a comprehensive report outlining bold reforms aimed at strengthening Europe\u2019s economy. While this vision addresses a broad range of sectors, the implications for the pharmaceutical industry are particularly notable. But what does this future look like, and how could these changes affect pharma companies? Let\u2019s dive into how Draghi\u2019s vision could reshape the pharmaceutical landscape in Europe. &nbsp; Boosting Investment in Pharma Innovation One of the key takeaways from Draghi\u2019s report is the call for Europe to significantly ramp up its investments in research and development (R&amp;D). For the pharmaceutical industry, which thrives on innovation, this could be a game-changer. The proposal suggests that Europe should raise its investment levels by up to \u20ac800 billion a year across various sectors. Given that R&amp;D forms the backbone of the pharma industry, this injection of funds could accelerate the development of new drugs and medical technologies, positioning European companies to compete more effectively with global players. &nbsp; Streamlining Regulatory Processes for Faster Approvals Pharmaceutical companies often face long and complex approval processes when bringing new treatments to...","og_url":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/","og_site_name":"ChemSafe","article_published_time":"2024-10-08T07:52:05+00:00","article_modified_time":"2024-10-08T08:34:53+00:00","og_image":[{"width":1280,"height":1024,"url":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg","type":"image\/jpeg"}],"author":"Gabriele Pincitore","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Gabriele Pincitore","Tempo di lettura stimato":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#article","isPartOf":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/"},"author":{"name":"Gabriele Pincitore","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119"},"headline":"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry","datePublished":"2024-10-08T07:52:05+00:00","dateModified":"2024-10-08T08:34:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/"},"wordCount":458,"publisher":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#organization"},"image":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg","articleSection":["Blog","Pharma"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/","url":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/","name":"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry - ChemSafe","isPartOf":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage"},"image":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg","datePublished":"2024-10-08T07:52:05+00:00","dateModified":"2024-10-08T08:34:53+00:00","breadcrumb":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#primaryimage","url":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg","contentUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2024\/10\/Mario-Draghi.jpg","width":1280,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/how-mario-draghis-vision-for-european-competitiveness-could-transform-the-pharma-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.chemsafe-consulting.com\/it\/"},{"@type":"ListItem","position":2,"name":"How Mario Draghi\u2019s Vision for European Competitiveness Could Transform the Pharma Industry"}]},{"@type":"WebSite","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#website","url":"https:\/\/www.chemsafe-consulting.com\/it\/","name":"ChemSafe","description":"Your lighthouse in a sea of rules","publisher":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.chemsafe-consulting.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#organization","name":"ChemSafe","url":"https:\/\/www.chemsafe-consulting.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png","contentUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png","width":170,"height":69,"caption":"ChemSafe"},"image":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/chemsafe-srl\/"]},{"@type":"Person","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119","name":"Gabriele Pincitore","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g","caption":"Gabriele Pincitore"},"url":"https:\/\/www.chemsafe-consulting.com\/it\/author\/chemsafe\/"}]}},"_links":{"self":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts\/26143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/comments?post=26143"}],"version-history":[{"count":2,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts\/26143\/revisions"}],"predecessor-version":[{"id":26147,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts\/26143\/revisions\/26147"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/media\/26144"}],"wp:attachment":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/media?parent=26143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/categories?post=26143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/tags?post=26143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}